FTC Inks 2nd Highest Disgorgement Deal With Cardinal Health
By Melissa Lipman (April 20, 2015, 12:09 PM EDT) -- Cardinal Health Inc. on Monday agreed to pay $26.8 million to resolve the Federal Trade Commission's claim that it illegally monopolized the sale of low-energy radiopharmaceuticals to health care providers in 25 areas, in the watchdog's second-highest antitrust disgorgement deal ever.
The FTC accused Cardinal Health of inflating prices of the drugs sold to hospitals and clinics across the country, and required the company to disgorge the profits it received from the alleged monopolization. It marks the agency's first disgorgement win in a competition case in nearly a decade.
The settlement also blocks Cardinal from signing simultaneous exclusive deals with rival...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!